Endotherapy Devices Market - By Product, By Application, By End Use - Global Forecast, 2026 - 2035

Based on product, the endotherapy devices market is segmented into gastrointestinal devices & accessories, endoscopic retrograde cholangiopancreatography (ERCP) devices & accessories, and other products. The gastrointestinal devices & accessories segment has asserted its dominance in the market by securing a significant market share of 56.4% in 2025 owing to the high volume of GI endoscopic procedures, widespread use of therapeutic accessories in routine interventions, and the rising prevalence of gastrointestinal disorders globally. The segment is expected to exceed USD 6.5 billion by 2035, growing at a CAGR of 7.4% during the forecast period.
 

On the other hand, the endoscopic retrograde cholangiopancreatography (ERCP) devices & accessories segment is expected to grow with a CAGR of 8.3%. The growth of this segment is driven by the increasing incidence of biliary and pancreatic disorders, rising preference for minimally invasive ERCP procedures over surgical alternatives, and continuous advancements in stents, guidewires, and sphincterotomy devices.
 

• The gastrointestinal devices & accessories segment continues to dominate the market. The rising prevalence of colorectal cancer, inflammatory bowel disease, GERD, and GI bleeding is boosting endoscopic procedure volume. GI endotherapy devices are crucial for diagnosing and treating these disorders.
   
• Additionally, government and payer-supported screening programs are expanding colonoscopy and endoscopic polypectomy procedures. This immediately increases demand for gastrointestinal attachments such snares, forceps, clips, and biopsy equipment.
   
• The endoscopic retrograde cholangiopancreatography (ERCP) devices & accessories segment held a revenue of USD 1.7 billion in 2025, with projections indicating a steady expansion at 8.3% CAGR from 2026 to 2035. The segment is driven by expanding availability of advanced imaging and fluoroscopy-guided endoscopy suites, increasing adoption in tertiary care hospitals, and rising clinical emphasis on early intervention for complex pancreaticobiliary conditions.
   

Based on application, the endotherapy devices market is segmented into gastrointestinal endoscopy, laparoscopy, arthroscopy, urology endotherapy, bronchoscopy, and other applications. The gastrointestinal endoscopy segment dominated the market in 2025, accounting for USD 3.1 billion and is anticipated to grow at a CAGR of 7.9% during the forecast period.
 

• Gastrointestinal endoscopy is increasingly used for therapeutic interventions such as EMR, ESD, hemostasis, and stent placement. These procedures reduce the need for open surgery and hospital stays. Hospitals favour endoscopy due to better outcomes and cost efficiency.
   
• Additionally, national screening initiatives and preventive healthcare policies are boosting colonoscopy adoption. GI endoscopy is the gold standard for early cancer detection and polyp removal. This directly supports sustained procedural and device demand.
   
• The laparoscopy segment accounted for significant revenue in 2025 and is anticipated to grow at a CAGR of 8.4% over the forecast period. The growth of this segment is driven by expanding surgical indications across gynecology, general surgery, and oncology, supported by surgeon training programs and increasing preference for day-care surgical procedures.
   
• The arthroscopy segment accounted for significant revenue in 2025 and is anticipated to grow at a CAGR of 6.8% over the forecast period. The segment driven by rising sports-related injuries, increasing orthopedic procedures among the aging population, and wider use of minimally invasive joint repair techniques.
   

Learn more about the key segments shaping this market

Download Free PDF

Based on end use, the endotherapy devices market is classified into hospitals, ambulatory surgical centers, and other end users. The hospitals segment dominated the market with a revenue share of 54.6% in 2025 and is expected to reach USD 6.2 billion within the forecast period.
 

• Hospitals manage a large and diverse patient population, resulting in higher volumes of endoscopic and therapeutic procedures. Emergency, complex, and multidisciplinary cases are typically handled in hospital settings. This creates a consistent demand for advanced endotherapy devices.
   
• Further, hospitals are equipped with advanced endoscopy suites, imaging systems, and trained gastroenterologists, urologists, and surgeons. This enables the use of complex endotherapy techniques. The presence of multidisciplinary teams supports higher device utilization.
   
• The ambulatory surgical centers segment accounted for significant revenue in 2025 and is anticipated to grow at a CAGR of 8.2% over the forecast period. The growth of the segment is being driven by favourable reimbursement for outpatient procedures, lower operating costs than hospitals, and an increasing patient preference for same-day minimally invasive treatments.

Looking for region specific data?

Download Free PDF

North America Endotherapy Devices Market
 

North America dominated the global market with the highest market share of 43.9% in 2025.
 

• The U.S. market was valued at USD 1.9 billion and USD 2.1 billion in 2022 and 2023, respectively. The market size reached USD 2.3 billion in 2025, growing from USD 2.2 billion in 2024, and is anticipated to grow at a CAGR of 6.6% between 2026 to 2035.
   
• North America is the leading region for sophisticated endotherapy techniques such as EMR, ESD, endoscopic suturing, and stenting. Higher procedural complexity is supported by strong clinical expertise and the early adoption of novel technology. This creates a demand for premium and next-generation endotherapy systems.
   
• Established reimbursement structures in the U.S. and Canada cover diagnostic and therapeutic endoscopic treatments. Private insurance and government initiatives encourage hospitals to invest in modern endotherapy equipment. This maintains constant procedure volumes and device use.
  
   

Europe Endotherapy Devices Market
 

Europe market accounted for USD 1.3 billion in 2025 and is anticipated to show lucrative growth over the forecast period.
 

• Most European countries operate publicly funded healthcare models that ensure broad patient access to endoscopic care. National screening programs increase procedural volumes. This institutional support drives stable demand for endotherapy devices.
   
• Strict regulatory norms and infection prevention policies are accelerating adoption of disposable and single-use endotherapy accessories. Hospitals prioritize devices that reduce cross-contamination risks. This trend supports higher accessory consumption.
   
• Further, many European hospitals are upgrading legacy endoscopy systems to advanced platforms. EU funding and national modernization programs support equipment replacement. This contributes to sustained, incremental market growth.
  
   

Asia Pacific Endotherapy Devices Market
 

The Asia Pacific market is anticipated to grow at the highest CAGR of 9% during the analysis timeframe.
 

• Asia Pacific accounts for a significant share of global GI cancers, liver diseases, and urological disorders. A high population density results in large procedure volumes. This creates a significant underlying demand for endotherapy devices.
   
• Countries such as China, India, and Southeast Asia are making significant investments in hospital expansion. Endoscopy units are being established in both urban and secondary cities. This infrastructure expansion directly increases device adoption.
   
• Moreover, improved physician training in advanced endoscopic techniques is expanding procedural capabilities. International collaborations and workshops support skill enhancement. This enables wider use of complex endotherapy devices.
  
   

Latin America Endotherapy Devices Market
 

The Latin America market is experiencing robust growth over the analysis timeframe.
 

• Public and private hospitals are upgrading diagnostic and therapeutic capabilities. Investment in endoscopy units is improving access to minimally invasive care. This fuels steady adoption of endotherapy devices.
   
• Exposure to international clinical standards is improving endoscopy adoption. Physicians are increasingly trained in therapeutic endoscopy techniques. This expands the scope of procedures performed using endotherapy devices.
  
   

Middle East & Africa Endotherapy Devices Market
 

The Middle East & Africa market is experiencing robust growth over the analysis timeframe.
 

• Gulf countries are heavily investing in advanced hospitals and specialty care centers. These facilities adopt modern endotherapy technologies to meet international standards. This drives high-value device demand in select markets.
   
• Limited availability of specialized surgeons in some MEA countries favours endoscopic interventions. Endotherapy reduces reliance on complex surgical setups. This encourages adoption in resource-constrained settings.
  
   

Endotherapy Devices Market Share

The global market is moderately consolidated, characterized by the presence of large multinational medical device companies alongside a growing number of regional and niche players. Leading companies compete on the basis of broad product portfolios, technological innovation, global distribution networks, and strong relationships with hospitals and physicians. Continuous investment in R&D and clinical validation remains a critical factor for sustaining competitive advantage.
 

Key players include Boston Scientific, Cook Medical, Medtronic, MICRO-TECH, and OLYMPUS, collectively accounting for ~65% of the total market share. These companies focus on expanding their therapeutic endoscopy offerings through new product launches, portfolio expansions, and regulatory approvals.
 

Strategic initiatives such as mergers, acquisitions, partnerships, and geographic expansion particularly in Asia Pacific and emerging markets are intensifying competition. Smaller players compete by offering cost-effective solutions, single-use accessories, and specialized devices tailored to specific clinical applications, increasing overall market dynamism.
 

Endotherapy Devices Market Companies

A few of the prominent players operating in the endotherapy devices industry include:
 

• B. BRAUN
• Boston Scientific
• CONMED
• Cook Medical
• Endo-Med
• FUJIFILM
• Johnson & Johnson
• KARL STORZ
• M.I. Tech
• Medtronic
• MICRO-TECH
• OLYMPUS
• Smith+Nephew
• Stryker
• TAEWOONG MEDICAL
  
   
• Boston Scientific

Its comprehensive endotherapy portfolio spanning GI, biliary, and urology therapeutic solutions, backed by strong clinical evidence and dedicated physician training programs. Their focus on innovation and procedural efficiency enhances clinical outcomes and reinforces long-term customer loyalty globally.
 

• OLYMPUS

OLYMPUS stands out with its market-leading imaging systems and integrated endoscopy platforms that deliver superior visualization and precision, strengthening the performance of endotherapy devices. Extensive global sales and service networks further ensure strong after-sales support and widespread clinical adoption.
 

• Cook Medical

Cook Medical’s deep expertise in minimally invasive technologies, particularly in niche segments like ERCP, biliary stenting, and therapeutic accessories that combine reliability with procedural versatility. Their emphasis on customizable solutions and long-standing clinician partnerships supports strong penetration in specialized endotherapy applications.
 

Endotherapy Devices Industry News:

• In April 2025, Olympus expanded its advanced bipolar surgical energy portfolio in Mexico with the launch of the POWERSEAL Sealer/Divider family, including 5mm Curved Jaw Double-Action devices in multiple lengths. This development strengthened the company’s competitive position by enhancing precision and efficiency in minimally invasive endoscopic and laparoscopic procedures. It supported market growth by improving access to advanced energy solutions and encouraging wider adoption of endotherapy technologies.
   
• In June 2024, B. Braun announced the launch of its ACCEL All-Purpose and Biliary Drainage Catheters with TrueGlide Hydrophilic Coating for percutaneous drainage, designed to enhance patient comfort and clinical performance. The product improved procedural efficiency through smoother insertion and higher drainage capacity, enabled by its advanced catheter design. This launch supported the market by expanding minimally invasive drainage solutions and strengthening innovation in biliary and interventional endotherapy applications.
   
• In May 2024, Cook Medical launched the next-generation EchoTip ClearCore Endoscopic Ultrasound (EUS) Biopsy Needle in the U.S., designed for fine needle biopsies of submucosal and extramural lesions, mediastinal masses, lymph nodes, and intraperitoneal masses near the gastrointestinal tract. The device enhanced diagnostic accuracy and procedural efficiency in EUS-guided interventions. This launch supported the market by expanding advanced biopsy solutions and promoting adoption of minimally invasive gastrointestinal diagnostic procedures.